Why the study?
Does the comprehensive treatment plan based on life support improve survival in patients with fulminant myocarditis?
Does the comprehensive treatment plan based on life support improve survival in patients with fulminant myocarditis?
Answers are grounded in this paper and cite their sources.
The Chinese expert consensus regimen for fulminant myocarditis, utilizing mechanical circulatory support and immunomodulation, is promoted to reduce mortality to approximately 5%.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: